Workflow
公司基本面改善
icon
Search documents
科思股份:底部已现,关注基本面改善进展-20260213
HTSC· 2026-02-13 02:30
Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 16.10 [1]. Core Views - The company is currently at a low point in its fundamentals, but several positive factors are accumulating. Inventory destocking by downstream major clients is nearing its end, and there is limited downside for the company's profitability and order prices, with potential for improvement. The new factory in Malaysia, market entry in the US, and new product lines are expected to contribute positively. Therefore, it is anticipated that the company's sales will recover to positive growth in 2026, with price stabilization and improvement potential [1][6][9]. Summary by Sections Supply and Demand - The destocking effect from downstream clients is expected to diminish, leading to a recovery in demand. The company's revenue decline has narrowed significantly, and the impact of destocking is gradually weakening, which may drive a gradual recovery in orders [7]. Price Dynamics - The company’s main raw materials are linked to oil prices, and recent geopolitical tensions have caused international oil prices to rise. This, combined with pre-holiday inventory replenishment, has improved the price differentials of most chemical products. Therefore, there is limited room for further price declines, with potential for upward price adjustments [8]. Sales Growth Potential - The new factory in Malaysia is nearing completion, with trial production preparations underway. The company is also promoting new products such as amino acid surfactants and anti-dandruff agents, which are entering major brand supply chains. Additionally, the US FDA certification for P-S products is progressing, which could open new growth avenues in the US market, the largest sunscreen market globally [9]. Profit Forecast and Valuation - The forecast for net profit attributable to the parent company for 2025E-2027E is maintained at RMB 0.87 billion, RMB 1.64 billion, and RMB 2.47 billion, respectively. The target price has been adjusted to RMB 16.10, reflecting a 31x PE for 2027E, based on clear expectations for supply-demand improvement, potential price increases, and anticipated sales growth [10].